Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Dexcom Inc shares valued at $306,703 were sold by Dolan Matthew Vincent on May 15 ’24. At $126.58 per share, Dolan Matthew Vincent sold 2,423 shares. The insider’s holdings dropped to 40,075 shares worth approximately $5.03 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Brown Michael Jon sold 629 shares, netting a total of over 79,411 in proceeds. Following the sale of shares at $126.25 each, the insider now holds 68,212 shares.
Before that, Dolan Matthew Vincent had sold 1,990 shares from its account. In a trade valued at $274,242, the EVP Strategy and Corporate Dev traded Dexcom Inc shares for $137.81 each. Upon closing the transaction, the insider’s holdings decreased to 1,990 shares, worth approximately $5.32 million.
As published in their initiating research note from RBC Capital Mkts on March 12, 2024, Dexcom Inc [DXCM] has been an Outperform and the price target has been revised to $165. As of April 17, 2023, Raymond James has increased its “an Outperform” rating to a “Strong buy” for DXCM. Earlier on March 29, 2023, UBS initiated its rating. Their recommendation was “a Buy” for DXCM stock.
Analyzing DXCM Stock Performance
During the last five days, there has been a drop of approximately -4.78%. Over the course of the year, Dexcom Inc shares have jumped approximately 1.22%. Shares of the company reached a 52-week high of $142.00 on 03/26/24 and a 52-week low of $113.05 on 02/28/24. A 50-day SMA is recorded $132.83, while a 200-day SMA reached $115.10. Nevertheless, trading volume fell to 1.99 million shares from 2.09 million shares the previous day.
Support And Resistance Levels for Dexcom Inc (DXCM)
According to the 24-hour chart, there is a support level at 123.99, which, if violated, would cause prices to drop to 122.37. In the upper region, resistance lies at 128.59. The next price resistance is at 131.58. RSI (Relative Strength Index) is 41.10 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.14, which suggests the price will decrease in the coming days. Percent R is at 83.15%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
